Neurogenomics Market Size is valued at USD 1.7 Bn in 2024 and is predicted to reach USD 7.3 Bn by the year 2034 at a 16.2% CAGR during the forecast period for 2025-2034.
Neurogenomics is the study of how an organism's genome influences the development, structure, and function of its nervous system. It integrates neuroscience, genomics, and bioinformatics to explore how genes and their interactions shape neural processes, behaviours, and neurological disorders. Unlike neurogenetics, which focuses on single genes, neurogenomics examines genome-wide interactions, including transcriptomes, proteomes, and epigenomes, to provide a systems-level understanding of the brain.
The growing prevalence of neurological disorders, the falling cost of sequencing, and the growing application of advanced sequencing technologies in precision medicine and disease diagnostics are all driving the growth of the neurogenomics market. Furthermore, it is projected that rising awareness of neurological conditions, developing nations, and the expanding use of targeted medications would open up new opportunities for market players.
However, the market's expansion is being held back by the high cost of neurogenomics products, the poor likelihood of finding positive, actionable mutations for precision medicine, and the moral and legal concerns surrounding sequencing-based diagnosis. Additionally, rising R&D costs for pharmaceutical companies and better reimbursement and regulatory frameworks for gene sequencing are opening up new avenues for the near-term expansion of the neurogenomics market.
The Neurogenomics market is segmented based on offering, application, and end-user. Based on offering, the market consists of next-generation sequencing (NGS) [systems, kits & reagents (DNA extraction and amplification kits & reagents, library preparation and target enrichment kits & regents, quality control kits & reagents, other NGS kits & reagents)], polymerase chain reaction (PCR) [systems, kits & reagents (microarray+, readers & scanners, DNA and RNA microarray kits & reagents, protein microarray kits & reagents, tissue microarray kits & reagents)], and software & services. By application, the market is segmented into variant discovery, research applications, target identification, transcription factor binding analysis, functional studies, and clinical applications. By end-user, the market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and academic & research institutes.
The Next-Generation Sequencing (NGS) category is expected to hold a major global market share in 2024 because of the steady demand for consumables and the growing number of clinical and research uses for sequencing. The growing popularity of sequencing-based diagnostic techniques reinforces NGS's leading position. Additionally, the decrease in costs associated with NGS has made it possible for a greater number of labs and research institutions to use it, which has increased its acceptability. The potential of NGS to provide a wealth of genetic data facilitates the development of specialized treatment plans for neurological disorders. Furthermore, continuous advancements in NGS technologies have improved their accuracy and capability, making them invaluable resources for neurogenomics research.
The pharmaceutical & biotechnology key players held the largest share of the neurogenomics market because of their widespread use of state-of-the-art technologies for research and the huge amount of financing available for such endeavours. The increasing use of next-generation sequencing in drug research and development is one of the primary factors contributing to this industry's domination. Businesses are making significant investments in genomics to find new treatment targets and indicators for brain illnesses. Through the use of genetic data in clinical trials, they have improved patient classification, resulting in more fruitful and effective research initiatives.
The North American Neurogenomics market is expected to register the highest market share in revenue in the near future because of its substantial R&D expenditures, established healthcare system, and presence of significant biotechnology firms. The need for advanced genetic diagnoses and individualized treatment options has significantly increased due to the rising prevalence of neurological diseases, including Parkinson's and Alzheimer's. Additionally, the region's dominant position in this sector is reinforced by regulatory body support and accelerated approval processes for genomic medicines, positioning it as a hub for neurogenomics advances. In addition, Asia Pacific is projected to grow rapidly in the global Neurogenomics market, driven by a growing patient population, rising healthcare spending, and growing awareness. The integration of neurogenomics in this field is accelerating due to advancements in sequencing techniques and government programs that support genomics-focused healthcare. Additionally, the growing number of neurological diseases and the availability of reasonably priced genetic testing alternatives are expanding the application of neurogenomics.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.7 Bn |
|
Revenue Forecast In 2034 |
USD 7.3 Bn |
|
Growth Rate CAGR |
CAGR of 16.2% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Offering, Application, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Qiagen N.V., Agilent Technologies Inc., Oxford Nanopore Technologies Plc., Revvity Inc., Pacific Biosciences of California Inc. and MGI Tech Co. Ltd. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neurogenomics Market Snapshot
Chapter 4. Global Neurogenomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Neurogenomics Market Industry Trends
4.10. Global Neurogenomics Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Neurogenomics Market Segmentation 1: By Offering, Estimates & Trend Analysis
5.1. Market Share by Offering, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Offering:
5.2.1. Next-Generation Sequencing (NGS)
5.2.1.1. Systems
5.2.1.2. Kits & Reagents
5.2.1.2.1. DNA Extraction and Amplification Kits & Reagents
5.2.1.2.2. Library Preparation and Target Enrichment Kits & Regents
5.2.1.2.3. Quality Control Kits & Reagents
5.2.1.2.4. Other NGS Kits & Reagents
5.2.2. Polymerase Chain Reaction (PCR)
5.2.2.1. Systems
5.2.2.2. Kits & Reagents
5.2.2.2.1. Microarray+
5.2.2.2.2. Readers & Scanners
5.2.2.2.3. DNA and RNA Microarray Kits & Reagents
5.2.2.2.4. Protein Microarray Kits & Reagents
5.2.2.2.5. Tissue Microarray Kits & Reagents
5.2.3. Software & Services
Chapter 6. Neurogenomics Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Research Applications
6.2.2. Target Identification
6.2.3. Functional Studies
6.2.4. Variant Discovery
6.2.5. Transcription Factor Binding Analysis
6.2.6. Clinical Applications
Chapter 7. Neurogenomics Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Academic & Research Institutes
7.2.3. Hospitals & Diagnostic Laboratories
Chapter 8. Neurogenomics Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Neurogenomics Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.2.3. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.3.3. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.4.3. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.5.3. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.6.3. Middle East & Africa Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Illumina, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Offering/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. F. Hoffmann-La Roche Ltd (Switzerland)
9.2.4. Qiagen N. V.
9.2.5. Agilent Technologies Inc.
9.2.6. Revvity Inc.
9.2.7. Pacific Biosciences of California Inc
9.2.8. Danaher Corporation
9.2.9. Oxford Nanopore Technologies Plc.
9.2.10. MGI Tech Co. Ltd..
By Offering-
Neurogenomics Market By Application-
Neurogenomics Market By End-user-
Neurogenomics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
